TABLE 2.

Effect of Log Viral Load at ART Initiation on Mean Anthropometric and Lipid Subfraction Outcomes Over Time in Two Age Groups After Initiating Antiretroviral Therapy

	CLHIV <3 Years at ART Initiation (ABC/3TC/LPV/r)		CLHIV ≥3 Years at ART Initiation (ABC/3TC/EFV)
Antdropometric outcome*	Estimate†‡	P	Estimate†‡	P
LAZ	−0.30 (−0.57 to −0.03)	0.03	−0.29 (−0.60 to 0.02)§	0.07§
WAZ	−0.32 (−0.58 to −0.07)	0.01	−0.32 (−0.64 to 0.01)§	0.05§
BMIZ	−0.12 (−0.37 to 0.13)	0.34	−0.05 (−0.33 to 0.23)	0.70
Lipid subfraction outcome¶	Estimate†‡	P	Estimate†‡	P
TC	−6.17 (−12.9 to 0.52)	0.07	−3.06 (−9.97 to 3.85)	0.38
LDL	−6.45 (−12.1 to −0.77)	0.03	−4.32 (−10.5 to 1.81)	0.16
HDL	−0.76 (−3.07 to 1.56)	0.52	0.68 (−1.70 to 3.06)	0.57

^*Adjusted for age, sex, log HIV viral load, caregiver, and wealtd index.

^†Estimate represents tde mean difference in outcome per unit log viral load increase.

^‡95% confidence intervals in parentdeses.

^§Model included interaction term of (log HIV viral load)×(time).

^¶Adjusted for age, sex, log HIV viral load, caregiver, wealtd index, BMIZ, and skinfold ratio.